4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid → HCID 66930006, compound
Reaction equation
Cl.Cl.[CH:3]([N:6]1[CH2:12][CH2:11][CH2:10][NH:9][CH2:8][CH2:7]1)([CH3:5])[CH3:4].[CH3:13][C:14]1([CH3:30])[C:18]([CH3:20])([CH3:19])[O:17][B:16]([C:21]2[CH:29]=[CH:28][C:24]([C:25](O)=[O:26])=[CH:23][CH:22]=2)[O:15]1>>[CH:3]([N:6]1[CH2:12][CH2:11][CH2:10][N:9]([C:25]([C:24]2[CH:23]=[CH:22][C:21]([B:16]3[O:17][C:18]([CH3:20])([CH3:19])[C:14]([CH3:30])([CH3:13])[O:15]3)=[CH:29][CH:28]=2)=[O:26])[CH2:8][CH2:7]1)([CH3:5])[CH3:4]Participants
3
Procedure
The tile compound (D12) was prepared in a similar manner to Description 7 from 1-(isopropyl)-hexahydro-1H-1,4-diazepine (free base of D2) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid and isolated as a brown oil. LCMS electrospray (+ve) 373 (MH+).
Workup
- customisolated as a brown oil
Sources & evidence
- ORD record
- ord-97266cfab6d34c0382925b5a3cc1e4b0
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07846922B2
Reaction notes
Loading…